Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Published Online
on November 22, 2006

Stroke. 2006
Published online before print November 22, 2006, doi: 10.1161/01.STR.0000252027.53766.2b
A more recent version of this article appeared on January 1, 2007
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
38/1/41    most recent
01.STR.0000252027.53766.2bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voetsch, B.
Right arrow Articles by Loscalzo, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voetsch, B.
Right arrow Articles by Loscalzo, J.
Related Collections
Right arrow Other Stroke
Right arrow Genetics of cardiovascular disease
Right arrow Platelets
Right arrowRelated Article

Submitted on July 14, 2006
Revised on August 14, 2006
Accepted on September 11, 2006

Promoter Polymorphisms in the Plasma Glutathione Peroxidase (GPx-3) Gene. A Novel Risk Factor for Arterial Ischemic Stroke Among Young Adults and Children

Barbara Voetsch MD, PhD; Richard C. Jin BS; Charlene Bierl MD, PhD; Kelly S. Benke AB; Gili Kenet MD; Paolo Simioni MD, PhD; Filomena Ottaviano BS; Benito P. Damasceno MD, PhD; Joyce M. Annichino-Bizacchi MD, PhD; Diane E. Handy PhD; and Joseph Loscalzo MD, PhD*

From the Whitaker Cardiovascular Institute and Evans Department of Medicine (B.V., R.C.J., C.B., F.O., D.E.H., J.L.), Boston University School of Medicine, Boston, Mass; the Department of Neurology (B.V., B.P.D., J.M.A.-B.), State University of Campinas, Brazil; the Department of Medicine, Brigham and Women’s Hospital (R.C.J., F.O., D.E.H., J.L.), Harvard Medical School, Boston, Mass; the Bloomberg School of Public Health (K.S.B.), Johns Hopkins University, Baltimore, Md; the Institute of Thrombosis and Haemostasis (G.K.), Sheba Medical Center, Israel; the Department of Medical and Surgical Sciences (P.S.), University of Padua, Italy; and the Department of Neurology (B.V.), Brigham and Women’s Hospital, Massachusetts General Hospital, and Harvard Medical School, Boston, Mass.

* To whom correspondence should be addressed. E-mail: jloscalzo{at}partners.org.

Background and Purpose--Plasma glutathione peroxidase (GPx-3)-deficiency increases extracellular oxidant stress, decreases bioavailable nitric oxide, and promotes platelet activation. The aim of this study is to identify polymorphisms in the GPx-3 gene, examine their relationship to arterial ischemic stroke (AIS) in a large series of children and young adults, and determine their functional molecular consequences.

Methods--We studied the GPx-3 gene promoter from 123 young adults with idiopathic AIS and 123 age- and gender-matched controls by single-stranded conformational polymorphism and sequencing analysis. A second, independent population with childhood stroke was used for a replication study. We identified 8 novel, strongly linked polymorphisms in the GPx-3 gene promoter that formed 2 main haplotypes (H1 and H2). The transcriptional activity of the 2 most prevalent haplotypes was studied with luciferase reporter gene constructs.

Results--The H2 haplotype was over-represented in both patient populations and associated with an independent increase in the risk of AIS in young adults (odds ratio=2.07, 95% CI=1.03 to 4.47; P=0.034) and children (odds ratio=2.13, 95% CI=1.23 to 4.90; P=0.027). In adults simultaneously exposed to vascular risk factors, the risk of AIS approximately doubled (odds ratio=5.18, 95% CI=1.82 to 15.03; P<0.001). Transcriptional activity of the H2 haplotype was lower than that of the H1 haplotype, especially after upregulation by hypoxia (normalized relative luminescence: 3.54±0.32 versus 2.47±0.26; P=0.0083).

Conclusion--These findings indicate that a novel GPx-3 promoter haplotype is an independent risk factor for AIS in children and young adults. This haplotype reduces the gene’s transcriptional activity, thereby compromising gene expression and plasma antioxidant and antithrombotic activities.


Key words: oxidative stress • platelets • thrombosis


Related Article:

From Bench to Bedside and Back: The Value of Candidate Gene Association Studies in Translational Research
Carolyn Hoppe
Stroke 2007 38: 6. [Full Text] [PDF]



This article has been cited by other articles:


Home page
HypertensionHome page
F. B. Pipkin and on behalf of The Genetics of Preeclampsia Consorti
Smoking in Moderate/Severe Preeclampsia Worsens Pregnancy Outcome, but Smoking Cessation Limits the Damage
Hypertension, April 1, 2008; 51(4): 1042 - 1046.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
B. Voetsch, R. C. Jin, C. Bierl, L. Deus-Silva, E. C.S. Camargo, J. M. Annichino-Bizacchi, D. E. Handy, and J. Loscalzo
Role of Promoter Polymorphisms in the Plasma Glutathione Peroxidase (GPx-3) Gene as a Risk Factor for Cerebral Venous Thrombosis
Stroke, February 1, 2008; 39(2): 303 - 307.
[Abstract] [Full Text] [PDF]